Inovio Pharma (INO) Tops Q2 EPS by 18c
Inovio Pharma (NASDAQ: INO) reported Q2 EPS of ($0.07), $0.18 better than the analyst estimate of ($0.25).
For earnings history and earnings-related data on Inovio Pharma (INO) click here.
Inovio Pharma (NASDAQ: INO) reported Q2 EPS of ($0.07), $0.18 better than the analyst estimate of ($0.25).
For earnings history and earnings-related data on Inovio Pharma (INO) click here.